Federal Register / Vol. 87, No. 42 / Thursday, March 3, 2022 / Notices 12165 

Active ingredient: Mandestrobin (2RS)- 

2-{2-[(2,5-dimethylphenoxy)methyl] 

phenyl}-2-methoxy-N-methylacetamide. 

Product type: Fungicide. Proposed use: 

Vegetable, tuberous and corm, except 

potato, subgroup 1D. Contact: RD. 

4. EPA Registration Number: 59639– 

201. Docket ID number: EPA–HQ–OPP– 

2022–0101. Applicant: Valent U.S.A. 

LLC, 4600 Norris Canyon Road, P.O. 

Box 5075, San Ramon, CA 94583–0975. 

Active ingredient: Mandestrobin (2RS)- 

2-{2-[(2,5-dimethylphenoxy)methyl] 

phenyl}-2-methoxy-N-methylacetamide. 

Product type: Fungicide. Proposed use: 

Vegetable, tuberous and corm, except 

potato, subgroup 1D. Contact: RD. 

5. EPA File Symbol: 73049–LEA. 

Docket ID number: EPA–HQ–OPP– 

2022–0104. Applicant: Valent 

Biosciences LLC, 1910 Innovation Way, 

Suite 100, Libertyville, IL 60048. Active 

ingredient: Fenpropathrin at 4.0%; 

abamectin at 1.5%; octanoic acid at 

0.33%; nonanoic acid at 0.33%; 

decanoic acid at 0.33%). Product type: 

Insecticide. Proposed Use: Wide-area 

mosquito adulticide. Contact: RD. 

6. EPA Registration Numbers: 73314– 

6 and 73314–19. Docket ID number: 

EPA–HQ–OPP–2022–0100. Applicant: 

Novozymes BioAg, Inc., 3101 Custer 

Avenue, Milwaukee, WI 53209. Active 

ingredient: Lipo-chitooligosaccharides 

(LCOs) SP104. Product type: 

Biochemical Plant Growth Regulator 

(PGR). Proposed use: New foliar and infurrow applications for terrestrial, 

greenhouse, and nursery use. Contact: 

BPPD. 

7. EPA File Symbol: 90098–R. Docket 

ID number: EPA–HQ–OPP–2021–0965. 

Applicant: Central Garden & Pet, P.O. 

Box 1019, Salem, VA 24153–1019. 

Active ingredient: Transfluthrin. 

Product type: Insecticide. Proposed Use: 

Outdoors and semi enclosed areas. 

Contact: RD. 

8. EPA Registration Number: 91473–1. 

Docket ID number: EPA–HQ–OPP– 

2022–0127. Applicant: Seipasa, S.A., C/ 

Almudevar, No. 2, Tardienta (Huesca), 

22240, Spain, (c/o Walter G. Talarek, 

PC, 5153 Allison Marshall Drive, 

Warrenton, VA 20187). Active 

ingredient: Bacillus subtilis strain IAB/ 

BS03. Product type: Fungicide. 

Proposed use: Interiorscape 

applications. Contact: BPPD. 

9. File Symbol: 95058–R. Docket ID 

number: EPA–HQ–OPP–2021–0966. 

Applicant: Agroindustrial Kimitec S.L., 

Santa Marta, 13 Almeria, 04740, Spain 

(c/o Compliance Services International, 

7501 Bridgeport Way West, Lakewood, 

WA 98499). Active ingredient: 

Eucalyptus Oil. Product type: 

Insecticide/acaricide. Proposed use: For 

use on agricultural and ornamental food 

and non-food crops. Contact: BPPD. 

(Authority: 7 U.S.C. 136 et seq.) 

Dated: February 8, 2022. 

Delores Barber, 

Director, Information Technology and 

Resources Management Division, Office of 

Program Support. 

[FR Doc. 2022–04493 Filed 3–2–22; 8:45 am] 

BILLING CODE 6560–50–P 

EXECUTIVE OFFICE OF THE 

PRESIDENT 

Request for Information To Support 

the Development of a Federal Scientific 

Integrity Policy Framework 

AGENCY: White House Office of Science 

and Technology Policy (OSTP). 

ACTION: Notice of request for 

information (RFI). 

SUMMARY: The White House Office of 

Science and Technology Policy (OSTP) 

seeks information to assist in 

developing a framework for regular 

assessment and iterative improvement 

of agency scientific integrity policies 

and practices. This effort builds on the 

Scientific Integrity Task Force’s review 

of existing scientific integrity policies 

and practices, released in the January 

11, 2022 report, Protecting the Integrity 

of Government Science. 

DATES: Interested persons and 

organizations are invited to submit 

comments on or before 5:00 p.m. ET on 

April 4, 2022. 

ADDRESSES: Interested individuals and 

organizations should submit comments 

electronically to ScientificIntegrityRFI@

ostp.eop.gov and include ‘‘SI RFI’’ in the 

subject line of the email. Due to time 

constraints, mailed paper submissions 

will not be accepted, and electronic 

submissions received after the deadline 

cannot be ensured to be incorporated or 

taken into consideration. 

Instructions: Response to this RFI is 

voluntary. Each responding entity 

(individual or organization) is requested 

to submit only one response. OSTP 

welcomes any responses to inform and 

guide the work of OSTP. Please feel free 

to respond to one or as many prompts 

as you choose. Submission must not 

exceed 10 pages in 12 point or larger 

font, with a page number provided on 

each page. Responses should include 

the name of the person(s) or 

organization(s) filing the comment, as 

well as the respondent type (e.g., 

academic, advocacy, professional 

society, community-based organization, 

industry, trainee/student, member of the 

public, government, other). 

Respondent’s role in the organization 

may also be provided (e.g., researcher, 

faculty, student, program manager, 

journalist) on a voluntary basis. 

Comments containing references, 

studies, research, and other empirical 

data that are not widely published 

should include copies or electronic 

links of the referenced materials. No 

business proprietary information, 

copyrighted information, or personally 

identifiable information should be 

submitted in response to this RFI. If you 

submit scientific or technical studies or 

other results of scientific research, 

OSTP requests (but is not requiring) that 

you also provide the following 

information where it is available: (1) 

Identification of the funding source(s) 

and sponsoring organization(s) of the 

research; (2) the extent to which the 

research findings were reviewed by a 

potentially affected party prior to 

publication or submission to the docket, 

and identification of any such parties; 

and (3) the nature of any financial 

relationships (e.g., consulting 

agreements, expert witness support, or 

research funding) between investigators 

who conducted the research and any 

organization(s) or entities having a 

financial interest in Federal scientific 

integrity. Disclosure of such information 

is intended to promote transparency and 

scientific integrity of data and technical 

information submitted to the record. 

Please be aware that comments 

submitted in response to this RFI may 

be posted on OSTP’s website or 

otherwise released publicly. 

In accordance with FAR 15.202(3), 

responses to this notice are not offers 

and cannot be accepted by the Federal 

Government to form a binding contract. 

Additionally, those submitting 

responses are solely responsible for all 

expenses associated with response 

preparation. 

FOR FURTHER INFORMATION CONTACT: For 

additional information, please direct 

questions to Dr. Ryan Donohue at 202– 

456–4444 or ScientificIntegrity@

ostp.eop.gov. 

SUPPLEMENTARY INFORMATION: The 

framework will include assessment 

criteria that OSTP and agencies can use 

to inform, review, and improve the 

content and implementation of agency 

scientific-integrity policies. To support 

this framework, OSTP seeks information 

on: (1) How scientific integrity policies 

can address important and emergent 

issues of our time, including diversity, 

equity, inclusion and accessibility; new 

technologies; emerging modes of 

science; and coordination with related 

policy domains; (2) The criteria to 

evaluate scientific integrity policy 


khammond on DSKJM1Z7X2PROD with NOTICES
12166 Federal Register / Vol. 87, No. 42 / Thursday, March 3, 2022 / Notices 

content, implementation, outcomes and 

impacts in the Executive Branch; (3) 

How to ensure that scientific integrity 

evaluation findings lead to effective 

iterative improvement of Federal 

scientific integrity policy and practices; 

and (4) How to ensure the long-term 

viability and implementation of Federal 

scientific integrity policies, practices, 

and culture through future 

Administrations. 

Please note the purpose of this RFI is 

not to receive reports on alleged 

offenses that are in violation of Federal 

scientific integrity policies. If you have 

witnessed or experienced any harmful 

acts that may undermine scientific 

integrity and you would like to report 

these allegations, please contact the 

scientific integrity office or the Office of 

Inspector General at the relevant Federal 

agency. 

Background: On January 27, 2021, 

President Biden issued the Presidential 

Memorandum on Restoring Trust in 

Government Through Scientific 

Integrity and Evidence-Based 

Policymaking (2021 Presidential 

Memorandum). The 2021 Presidential 

Memorandum asserts the 

Administration’s goal to make evidencebased policy decisions guided by the 

best available science and data, 

recognizing that scientific and 

technological information, data, and 

evidence are central to the development 

and iterative improvement of sound 

policies and to the delivery of equitable 

programs across every area of 

government. The 2021 Presidential 

Memorandum emphasizes that political 

interference in the work of Federal 

scientists and other scientists who 

support the work of the Federal 

government and in the communication 

of scientific facts undermines the 

welfare of the Nation, contributes to 

systemic inequities and injustices, and 

violates the trust that the public places 

in government to best serve its 

collective interests. The 2021 

Presidential Memorandum reaffirms and 

builds on the Presidential Memorandum 

of March 9, 2009 (Scientific Integrity) 

and the Director of the Office of Science 

and Technology Policy’s Memorandum 

of December 17, 2010 (Scientific 

Integrity), which together specify 

elements that scientific integrity 

policies of Federal departments and 

agencies are to address. 

On January 11, 2022, OSTP issued a 

report of its Scientific Integrity Task 

Force titled, Protecting the Integrity of 

Government Science, that included an 

assessment of Federal scientific integrity 

policies and practices. Among other 

remarks on scientific integrity policies, 

the report stated that agencies need to 

strengthen scientific integrity policies to 

deter undue influence in the conduct, 

management, communication, and use 

of science; that violations involving 

high-level officials are the most 

problematic and difficult to address; 

and that further action is required to 

establish and maintain a culture of 

scientific integrity across all individuals 

and agencies that conduct, manage, 

communicate, and make use of science. 

The Task Force report also notes that a 

strong organizational culture of 

scientific integrity is a necessary 

foundation to reduce the potential for 

wrongdoing, protect against 

inappropriate influence, reinforce 

agency missions and goals, and ensure 

equitable delivery of Federal 

Government programs. The report made 

several recommendations. All Federal 

agencies—not just those that fund and 

conduct scientific research—need to 

develop, implement, and periodically 

review and update scientific integrity 

policies and that agencies need to apply 

scientific integrity policies to all those 

in Federal agencies who conduct, 

manage, communicate, or use science. 

Further, the report identified numerous 

good practices that Federal agencies can 

readily adopt and adapt for use as 

appropriate to their different missions 

and needs, including: (1) Fostering a 

culture of scientific integrity, which 

involves effective agency leadership and 

modeling of appropriate behaviors; (2) 

protecting the integrity of the research 

process; (3) communicating science 

with integrity, which entails effective 

and transparent communication of 

scientific information to decisionmakers, the media, and the American 

people; and (4) Safeguarding scientific 

integrity, which requires clear, visible 

procedures for reporting concerns, 

robust assessment and adjudication, and 

consistent enforcement of consequences 

when violations are found. Finally, the 

report recommended that scientific 

integrity policies be updated to address 

important and emergent issues of our 

time, including diversity, equity, 

inclusion, and accessibility; new 

technologies, including artificial 

intelligence and machine learning; 

emerging modes of science, such as 

citizen science and community-engaged 

research; and coordination with related 

policy domains, such as open data and 

promotion of safe, equitable workplaces. 

The 2021 Presidential Memorandum 

directs the development of a framework 

to inform and support the regular 

assessment and iterative improvement 

of agency scientific integrity policies 

and practices, to support the Director 

and OSTP in ensuring that agencies 

adhere to the principles of scientific 

integrity. This framework shall be 

completed 120 days after the release of 

the Task Force report and include 

assessment criteria that OSTP and 

agencies can use to inform, review, and 

improve the design and implementation 

of agency scientific-integrity policies. 

The Director shall publish this 

framework on the OSTP website. 

This request for information aims to 

support OSTP’s and the Task Force’s 

work to develop the framework for 

regular assessment and iterative 

improvement of agency scientific 

integrity policies and practices. This RFI 

is motivated by the Presidential 

Memorandum’s direction that the Task 

Force gather input from stakeholders 

and the public regarding the scientific 

integrity policies and practices and the 

Scientific Integrity Task Force’s 

previous listening sessions, which 

underscored the need for ongoing public 

engagement on scientific integrity and 

policymaking processes. 

Information Requested 

Respondents may provide information 

on one or as many topics below as they 

choose. Input is welcome from 

stakeholders and members of the public 

representing all backgrounds and 

perspectives. Through this RFI, OSTP 

seeks information on assessment and 

improvement of scientific integrity 

policies and practices in the Federal 

government, including on the following 

topics: 

1. Information is requested on how 

scientific integrity policies at Federal 

agencies and other components of the 

Executive Branch can be developed or 

updated to address important and 

emergent issues of our time, including: 

(1) Diversity, equity, inclusion, and 

accessibility, which are essential to 

advancing the conduct, communication, 

and use of science, ensuring the 

equitable delivery of government 

programs, and improving equitable 

participation in science by diverse 

communities across the Nation; (2) New 

technologies, such as artificial 

intelligence, machine learning, and the 

lack of transparency and potential for 

bias in computer algorithms and 

associated data; (3) Emerging modes of 

science, such as citizen science and 

community-engaged research; and (4) 

Coordination with related policy 

domains, such as open science and 

data; quality guidelines for data and 

information that agencies release; 

promotion of safe, equitable workplaces 

free from harassment and 

discrimination; and protection of 

research security and responding to 

research misconduct. 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 87, No. 42 / Thursday, March 3, 2022 / Notices 12167 

2. Information is requested on the 

criteria that should be used to evaluate 

scientific integrity policies: Content, 

implementation, outcomes, and impacts 

in Federal agencies and other 

components of the Executive Branch. 

Consider methods and metrics for 

evaluating elements such as, but not 

limited to: Policy provisions, practices, 

capacity, and actions so that 

determinations can be made on their 

efficacy to achieve desired outcomes 

and impacts. 

3. Information is requested on how to 

ensure that scientific integrity 

evaluation findings, and other findings 

that evolve over time, such as findings 

on the emergent issues identified above, 

lead to iterative improvement of Federal 

scientific integrity policy and practices. 

Consider information covering, but not 

limited to: Types and frequency of 

evaluation of agency scientific integrity 

policies and practices; steps that OSTP, 

Federal agencies, and other components 

of the Executive Branch should take to 

ensure regular comprehensive 

evaluation and continuous 

improvement of scientific integrity 

policies and practices; and other 

mechanisms or process elements that 

should be included in the framework to 

ensure effective iterative improvement 

of Federal scientific integrity policy and 

practices. 

4. Information is requested on how to 

ensure the long-term viability and 

implementation of Federal scientific 

integrity policies, practices, and culture 

through future Administrations. 

Consider information on, but not limited 

to: Ways to ensure Federal scientific 

integrity is robust through changes in 

government leadership, funding, and 

cultural shifts; how to institutionalize 

policies and practices that ensure the 

integrity of science, build and sustain a 

culture of scientific integrity, and 

encourage transparency; and how to 

provide accountability, such as through 

procedures to identify, address, and 

provide appropriate and meaningful 

consequences for instances when 

scientific integrity policies have been 

violated. 

Dated: February 28, 2022. 

Stacy Murphy, 

Operations Manager. 

[FR Doc. 2022–04466 Filed 3–2–22; 8:45 am] 

BILLING CODE 3270–F1–P 

FEDERAL COMMUNICATIONS 

COMMISSION 

[GN Docket No. 19–329; FR ID 73477] 

Federal Advisory Committee Act; Task 

Force for Reviewing the Connectivity 

and Technology Needs of Precision 

Agriculture in the United States 

AGENCY: Federal Communications 

Commission. 

ACTION: Notice of public meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, this 

notice advises interested persons that 

the Federal Communications 

Commission’s (FCC or Commission) 

Task Force for Reviewing the 

Connectivity and Technology Needs of 

Precision Agriculture in the United 

States (Task Force) will hold its next 

meeting via live internet link. 

DATES: March 21, 2022. The meeting 

will come to order at 10:00 a.m. EST. 

ADDRESSES: The meeting will be held 

via conference call and be available to 

the public via live feed from the FCC’s 

web page at www.fcc.gov/live. 

FOR FURTHER INFORMATION CONTACT: 

Elizabeth Cuttner, Designated Federal 

Officer, at (202) 418–2145, or 

Elizabeth.Cuttner@fcc.gov; Stacy 

Ferraro, Deputy Designated Federal 

Officer, at (202) 418–0795, or 

Stacy.Ferraro@fcc.gov; or Lauren Garry, 

Deputy Designated Federal Officer, at 

(202) 418–0942, or Lauren.Garry@

fcc.gov. 

SUPPLEMENTARY INFORMATION: The 

meeting will be held on March 21, 2022 

at 10:00 a.m. EST and may be viewed 

live, by the public, at http://

www.fcc.gov/live. Any questions that 

arise during the meeting should be sent 

to PrecisionAgTF@fcc.gov and will be 

answered at a later date. Members of the 

public may submit comments to the 

Task Force in the FCC’s Electronic 

Comment Filing System, ECFS, at 

www.fcc.gov/ecfs. Comments to the Task 

Force should be filed in GN Docket No. 

19–329. Open captioning will be 

provided for this event. Other 

reasonable accommodations for people 

with disabilities are available upon 

request. Requests for such 

accommodations should be submitted 

via email to fcc504@fcc.gov or by calling 

the Consumer & Governmental Affairs 

Bureau at (202) 418–0530 (voice). Such 

requests should include a detailed 

description of the accommodation 

needed. In addition, please include a 

way the FCC can contact you if it needs 

more information. Please allow at least 

five days’ advance notice; last-minute 

requests will be accepted but may not be 

possible to fill. 

Proposed Agenda: At this meeting, 

the Task Force will provide updates on 

Task Force administration; review and 

discuss programs and policies relevant 

to the Task Force’s duties; and continue 

to discuss strategies to advance 

broadband deployment on agricultural 

land and promote precision agriculture. 

This agenda may be modified at the 

discretion of the Task Force Chair and 

the Designated Federal Officer. 

Federal Communications Commission. 

Marlene Dortch, 

Secretary, Office of the Secretary. 

[FR Doc. 2022–04415 Filed 3–2–22; 8:45 am] 

BILLING CODE 6712–01–P 

FEDERAL COMMUNICATIONS 

COMMISSION 

[FR ID: 74524] 

Privacy Act of 1974; Matching Program 

AGENCY: Federal Communications 

Commission. 

ACTION: Notice of a new matching 

program. 

SUMMARY: In accordance with the 

Privacy Act of 1974, as amended 

(‘‘Privacy Act’’), this document 

announces a new computer matching 

program the Federal Communications 

Commission (‘‘FCC’’ or ‘‘Commission’’ 

or ‘‘Agency’’) and the Universal Service 

Administrative Company (USAC) will 

conduct with the Virginia Department of 

Social Services (‘‘Department’’) 

(‘‘Agency’’). The purpose of this 

matching program is to verify the 

eligibility of applicants to and 

subscribers of Lifeline, and the 

Affordable Connectivity Program (ACP), 

both of which are administered by 

USAC under the direction of the FCC. 

More information about these programs 

is provided in the SUPPLEMENTARY

INFORMATION section below. 

DATES: Written comments are due on or 

before April 4, 2022. This computer 

matching program will commence on 

April 4, 2022, and will conclude 18 

months after the effective date. 

ADDRESSES: Send comments to Linda 

Oliver, FCC, 45 L Street NE, 

Washington, DC 20554, or to Privacy@

fcc.gov. 

FOR FURTHER INFORMATION CONTACT: 

Linda Oliver at 202–418–1732 or 

Privacy@fcc.gov. 

SUPPLEMENTARY INFORMATION: The 

Lifeline program provides support for 

discounted broadband and voice 

services to low-income consumers. 


khammond on DSKJM1Z7X2PROD with NOTICES